ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,363 | -99.4% | 19,096 | -97.4% | 0.00% | -100.0% |
| Q3 2022 | $4,843,000 | +5.1% | 722,943 | -0.2% | 0.09% | -27.6% |
| Q2 2022 | $4,608,000 | +223.8% | 724,454 | +136.2% | 0.13% | +234.2% |
| Q1 2022 | $1,423,000 | +77.0% | 306,681 | +90.8% | 0.04% | +52.0% |
| Q4 2021 | $804,000 | -74.6% | 160,749 | +202.7% | 0.02% | -87.8% |
| Q4 2019 | $3,166,000 | -10.6% | 53,100 | -45.0% | 0.20% | -2.8% |
| Q3 2019 | $3,541,000 | +1357.2% | 96,600 | +1747.4% | 0.21% | +681.5% |
| Q2 2019 | $243,000 | -78.5% | 5,229 | -81.5% | 0.03% | -85.5% |
| Q1 2019 | $1,132,000 | – | 28,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |